Product Information

DEXTROAMP-AMPHET ER 20 MG CAP is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.6118 per EA under NDC 42858072001. Its NADAC has been published 350 times since Oct 16, 2019.

The Low Outlier badge above means this manufacturer's average price in the DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Low Outlier
DEA Schedule CII

Strength

5; 5; 5; 5 mg/1; mg/1; mg/1; mg/1

NDC

42858072001

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA210651

On Market Since

8/22/2019

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHET ER 20 MG CAP has been published 350 times since Oct 16, 2019, and over the history we have for it it has declined 67.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6118 per EA
All-time high$1.8791 (Oct 16, 2019)
All-time low$0.4163 (May 22, 2024)
52-week high$0.6945
52-week low$0.5929
Median price$0.6440
Average price$0.7753
Largest weekly change-33.5% (Sep 23, 2020)
Weeks tracked350
Tracking sinceOct 16, 2019

Price History

1W

0.0%

1M

+3.2%

3M

-1.2%

6M

-1.2%

1Y

-11.6%

3Y

-8.2%

5Y

-15.0%

All

-67.4%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHET ER 20 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 20 MG CAP, manufactured by Rhodes Pharmaceuticals L.P., is $0.6118 per EA (NDC 42858072001), effective Jun 24, 2026.

How has the price of DEXTROAMP-AMPHET ER 20 MG CAP changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 20 MG CAP has declined 67.4%. It has been tracked across 350 weekly CMS publications since Oct 16, 2019.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 20 MG CAP?

Since Oct 16, 2019, the NADAC for DEXTROAMP-AMPHET ER 20 MG CAP has ranged from a low of $0.4163 (May 22, 2024) to a high of $1.8791 (Oct 16, 2019), with a median of $0.6440 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHET ER 20 MG CAP?

2 NADAC-published products share the same active ingredient, strength, and dosage form as DEXTROAMP-AMPHET ER 20 MG CAP, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHET ER 20 MG CAP?

DEXTROAMP-AMPHET ER 20 MG CAP (NDC 42858072001) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.